UK markets close in 1 hour 1 minute

Arcutis Biotherapeutics, Inc. (ARQT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.55-0.05 (-0.58%)
As of 10:29AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5566
Avg. Estimate-0.73-0.67-2.42-1.33
Low estimate-0.91-0.87-3.14-1.88
High estimate-0.6-0.55-1.9-1.07
Year ago EPS-1.31-1.16-3.78-2.42
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5566
Avg. Estimate14.74M24.04M116.1M229.8M
Low estimate13.2M19.2M96.3M185.7M
High estimate17M28M140M260M
Year ago sales2.78M5.19M59.61M116.1M
Sales growth (year/est)430.00%363.20%94.80%97.90%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-1.28-1.25-0.86-0.77
Actual EPS-1.31-1.16-0.73-0.72
Difference-0.030.090.130.05
Surprise %-2.30%7.20%15.10%6.50%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.73-0.67-2.42-1.33
7 days ago-0.73-0.67-2.42-1.33
30 days ago-0.74-0.69-2.51-1.46
60 days ago-0.74-0.69-2.5-1.48
90 days ago-0.8-0.75-2.59-1.64
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1111
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesARQTIndustrySector(s)S&P 500
Current qtr.44.30%N/AN/AN/A
Next qtr.42.20%N/AN/AN/A
Current year36.00%N/AN/AN/A
Next year45.00%N/AN/AN/A
Next 5 years (per annum)9.80%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A